跳轉至內容
Merck
全部照片(1)

重要文件

1000420

USP

Abacavir Related Compound A

United States Pharmacopeia (USP) Reference Standard

同義詞:

(1S,4R)-4-[2,6-Diamino-9H-purin-9-yl]-2-cyclopentene-1-methanol

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C11H14N6O
CAS號碼:
124752-25-6
分子量：:
246.27
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

abacavir

製造商／商標名

USP

應用

pharmaceutical (small molecule)

形式

neat

儲存溫度

2-8°C

InChI

1S/C11H14N6O/c12-9-8-10(16-11(13)15-9)17(5-14-8)7-2-1-6(3-7)4-18/h1-2,5-7,18H,3-4H2,(H4,12,13,15,16)/t6-,7+/m1/s1

InChI 密鑰

ZKJUXHDSLJYKED-RQJHMYQMSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Abacavir Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

相關產品

產品號碼
描述
訂價

1000485

Abacavir Related Compounds Mixture, United States Pharmacopeia (USP) Reference Standard

1000496

Abacavir Stereoisomers Mixture, United States Pharmacopeia (USP) Reference Standard

1000500

Abacavir System Suitability Mixture, United States Pharmacopeia (USP) Reference Standard

1000408

硫酸阿巴卡韦 硫酸酯, United States Pharmacopeia (USP) Reference Standard

1000419

Abacavir sulfate racemic, United States Pharmacopeia (USP) Reference Standard

1000441

Abacavir Related Compound B, United States Pharmacopeia (USP) Reference Standard

1000452

Abacavir Related Compound C, United States Pharmacopeia (USP) Reference Standard

PHR1256

硫酸阿巴卡韦, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001561

硫酸阿巴卡韦 硫酸酯, European Pharmacopoeia (EP) Reference Standard

Y0001551

阿巴卡韦, European Pharmacopoeia (EP) Reference Standard

Y0001552

阿巴卡韦, European Pharmacopoeia (EP) Reference Standard

1000437

Abacavir Related Compound D, United States Pharmacopeia (USP) Reference Standard

BP1112

硫酸阿巴卡韦 硫酸酯, British Pharmacopoeia (BP) Reference Standard

BP1113

阿巴卡韦杂质标准品, British Pharmacopoeia (BP) Reference Standard

BP1114

Abacavir Impurity 1, British Pharmacopoeia (BP) Reference Standard

PHR2074

Abacavir Impurity F, pharmaceutical secondary standard, certified reference material

象形圖

Corrosion
GHS05

訊號詞

Danger

危險聲明

H318

危險分類

Eye Dam. 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number

抱歉，我們目前沒有在線上提供本產品的COA

如果您需要協助，請聯絡 客戶支援

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

C L Zimmerman et al.
Drug metabolism and disposition: the biological fate of chemicals, 28(6), 672-679 (2000-05-23)
A CBV [(-)-carbovir, (-)-carbocyclic 2',3'-didehydro-2', 3'-dideoxyguanosine] prodrug, 6AC [(-)-6-aminocarbovir, (-)-carbocyclic 2',3'-didehydro-2', 3'-dideoxy-6-deoxy-6-aminoguanosine], was previously evaluated in rats, and it exhibited superiority to the parent drug in increasing systemic and central nervous system exposure to CBV. The gut wall was determined
R L Yeager et al.
Drug metabolism and disposition: the biological fate of chemicals, 19(2), 462-466 (1991-03-01)
The potential for the metabolic conversion of (-)-6-aminocarbovir to (-)-carbovir, a potent reverse transcriptase inhibitor effective against human immunodeficiency virus, has been examined in male Sprague-Dawley rats. Plasma (-)-6-aminocarbovir concentrations declined rapidly in a biphasic manner following an iv bolus
Y Wen et al.
Drug metabolism and disposition: the biological fate of chemicals, 27(1), 113-121 (1999-01-12)
Several in vitro and in situ approaches were used to determine the dominant presystemic activation site for (-)-6-aminocarbovir, (-)-carbocyclic 2',3'-didehydro-2', 3'-dideoxy-6-deoxy-6-aminoguanosine (6AC) conversion in rats. The in vitro disappearance half-lives (mean +/- S.D.) in the cytosolic fractions obtained from homogenates
Lack of effect of catheterization on the pharmacokinetics of (-)-carbovir in rats.
C L Zimmerman et al.
Pharmaceutical research, 13(9), 1417-1418 (1996-09-01)
C L Zimmerman et al.
Drug metabolism and disposition: the biological fate of chemicals, 20(1), 47-51 (1992-01-01)
The recently synthesized carbocyclic 2',3'-didehydro-2',3'-dideoxy-6-deoxy-6-amino-guanosine [(-)6AC] was evaluated as a prodrug for carbovir, carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine [(-)CBV] in seven male Sprague-Dawley rats. A randomized three-way cross-over design was used. Rats were assigned to receive the following treatments: a 20 mg/kg (-)6AC
查看所有相關論文

相關內容

Small Molecule HPLC

Small molecules are ions and compounds of molecular weight typically less than 900 daltons. These compounds can be effectively separated and analyzed by HPLC, UHPLC and LC-MS using mainly silica particles or monolithic stationary phases with a broad range of column chemistries (modifications).

Small Molecule HPLC

Small molecules are ions and compounds of molecular weight typically less than 900 daltons. These compounds can be effectively separated and analyzed by HPLC, UHPLC and LC-MS using mainly silica particles or monolithic stationary phases with a broad range of column chemistries (modifications).

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務